SB has been shown to reverse the downregulation of the PI3K/Akt signaling pathway caused by 6-OHDA in vitro and to reverse ataxia in a zebrafish model of PD in vivo (Feng et al., 2019). The gene discussed is AKT1; the disease is Parkinson disease.